Physician
West Tennessee Medical Group INC
West Tennessee Medical Group INC was paid $8.19M by Medicaid between Jan 2018 and Dec 2024, across 164 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 19% of everything it billed.
33Billing provider infoWEST TENNESSEE MEDICAL GROUP INC
JACKSON, TN 38301
JACKSON, TN 38301
33aNPI1053615955assigned 01/06/2011
33bProvider typeTrauma Surgery Physician
28Total paid$8.19M
24GClaims415,846
24DCodes billed164
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Trauma Surgery Physician providers in Tennessee
Rank by total paid#1 of 5
Median peer was paid$31K
This provider vs. median268×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 63,080 | $1.73M | |
| 2019 | 61,814 | $1.62M | |
| 2020 | 33,232 | $1.01M | |
| 2021 | 34,815 | $684K | |
| 2022 | 65,140 | $1.02M | |
| 2023 | 75,538 | $1.21M | |
| 2024incomplete | 82,227 | $916K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 50,370 | 42,536 | $1.57M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 37,178 | 30,890 | $1.40M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 7.6% | 35,124 | 13,025 | $625K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 7.3% | 994 | 683 | $600K |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | 5.5% | 329 | 285 | $453K |
| 99223 | Prolong inpt eval add15 m | 5.5% | 9,213 | 7,950 | $450K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.9% | 6,317 | 5,302 | $405K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.5% | 5,108 | 4,466 | $285K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 3.1% | 10,327 | 4,916 | $254K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2.4% | 2,183 | 1,824 | $193K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 2.2% | 926 | 811 | $183K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.8% | 3,009 | 2,556 | $147K |
152 more codes
| 95816 | 1.5% | 2,022 | $120K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 1.3% | 1,107 | $105K |
| 99239 | Hospital discharge day management, more than 30 minutes | 1.3% | 4,169 | $104K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 2,003 | $75K |
| 59025 | Fetal non-stress test | <1% | 2,237 | $66K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 1,391 | $62K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 5,185 | $54K |
| 99283 | Emergency room visit (moderate) | <1% | 989 | $50K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,313 | $49K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 4,593 | $46K |
| 99220 | <1% | 944 | $46K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 15,026 | $45K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 856 | $44K |
| 99205 | Prolong outpt/office vis | <1% | 509 | $41K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 3,054 | $41K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,810 | $40K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 286 | $37K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,516 | $32K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 764 | $32K |
| 99383 | <1% | 339 | $29K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 420 | $28K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 185 | $28K |
| 95886 | <1% | 543 | $24K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 2,056 | $24K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 687 | $22K |
| 64615 | <1% | 265 | $21K | |
| 59425 | <1% | 62 | $20K | |
| 59510 | <1% | 13 | $20K | |
| 93000 | <1% | 2,110 | $19K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,612 | $18K |
| 81025 | <1% | 3,151 | $16K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 210 | $15K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 316 | $14K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 623 | $13K |
| 59426 | <1% | 22 | $13K | |
| 99384 | <1% | 143 | $12K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 121 | $9K |
| 43248 | <1% | 137 | $9K | |
| 87631 | <1% | 102 | $9K | |
| 72110 | <1% | 646 | $9K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,568 | $8K |
| 99173 | <1% | 1,643 | $7K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 555 | $7K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 293 | $7K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 98 | $7K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 18 | $6K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 125 | $6K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 268 | $6K |
| 81003 | <1% | 3,524 | $6K | |
| 99217 | <1% | 221 | $5K | |
| 20553 | <1% | 175 | $5K | |
| 94060 | <1% | 252 | $5K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 84 | $5K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 65 | $4K |
| 94729 | <1% | 198 | $4K | |
| 92551 | <1% | 515 | $4K | |
| 99459 | <1% | 245 | $4K | |
| 96118 | <1% | 30 | $4K | |
| 3008F | <1% | 79,066 | $4K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 815 | $3K |
| 94726 | <1% | 150 | $3K | |
| 1111F | <1% | 3,283 | $3K | |
| 96127 | <1% | 457 | $3K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 78 | $3K |
| 92552 | <1% | 134 | $3K | |
| 95909 | <1% | 35 | $2K | |
| 99307 | <1% | 424 | $2K | |
| 96132 | <1% | 92 | $2K | |
| 96137 | <1% | 97 | $2K | |
| 99255 | <1% | 15 | $2K | |
| 96160 | <1% | 149 | $2K | |
| 96136 | <1% | 147 | $1K | |
| 3078F | <1% | 7,179 | $1K | |
| 0503F | <1% | 980 | $1K | |
| 99382 | <1% | 16 | $1K | |
| 90686 | <1% | 579 | $1K | |
| 99442 | <1% | 60 | $1K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 225 | $968.60 |
| 90756 | <1% | 107 | $960.04 | |
| 99497 | <1% | 172 | $934.80 | |
| 3074F | <1% | 6,455 | $781.45 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 411 | $712.41 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 28 | $709.64 |
| 99406 | <1% | 200 | $690.26 | |
| 90651 | <1% | 580 | $684.02 | |
| 3079F | <1% | 1,761 | $660.05 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 374 | $632.60 |
| 96101 | <1% | 14 | $617.12 | |
| 95885 | <1% | 12 | $600.80 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 101 | $594.97 |
| 96130 | <1% | 18 | $540.52 | |
| 90682 | <1% | 15 | $531.41 | |
| 1159F | <1% | 10,796 | $491.71 | |
| 3077F | <1% | 955 | $460.02 | |
| 1160F | <1% | 7,341 | $395.06 | |
| 90674 | <1% | 29 | $360.68 | |
| 90734 | <1% | 350 | $325.72 | |
| 99219 | <1% | 15 | $325.38 | |
| 90688 | <1% | 39 | $324.69 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 88 | $307.90 |
| 93296 | <1% | 32 | $279.77 | |
| 1126F | <1% | 231 | $276.78 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 172 | $268.76 |
| 99221 | <1% | 13 | $251.03 | |
| 73630 | <1% | 13 | $227.57 | |
| 99305 | <1% | 33 | $215.29 | |
| 93227 | <1% | 14 | $201.26 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 15 | $170.16 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 28 | $163.98 |
| 90715 | <1% | 470 | $163.21 | |
| 72040 | <1% | 15 | $155.09 | |
| 93016 | <1% | 18 | $147.54 | |
| 90716 | <1% | 111 | $147.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 26 | $142.73 |
| 1125F | <1% | 117 | $140.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 92 | $132.02 |
| 93018 | <1% | 19 | $129.61 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 105 | $106.84 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 328 | $106.11 |
| 90707 | <1% | 108 | $99.52 | |
| 3075F | <1% | 527 | $80.00 | |
| 81002 | <1% | 30 | $73.40 | |
| 72100 | <1% | 13 | $69.82 | |
| 51798 | <1% | 26 | $69.24 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 69 | $63.56 |
| 80053 | Comprehensive metabolic panel | <1% | 209 | $40.58 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 18 | $20.96 |
| G0008 | Administration of influenza virus vaccine | <1% | 61 | $17.80 |
| 94760 | <1% | 23 | $16.21 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 50 | $12.79 |
| 3080F | <1% | 96 | $10.00 | |
| 0502F | <1% | 16,960 | $10.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 18 | $8.50 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 34 | $1.92 |
| 99024 | 0% | 1,267 | $0.00 | |
| 3061F | 0% | 21,985 | $0.00 | |
| 2001F | 0% | 1,052 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 126 | $0.00 |
| 90696 | 0% | 54 | $0.00 | |
| 4010F | 0% | 707 | $0.00 | |
| 1036F | 0% | 190 | $0.00 | |
| 2000F | 0% | 1,057 | $0.00 | |
| 3044F | 0% | 56 | $0.00 | |
| 1170F | 0% | 76 | $0.00 | |
| 1101F | 0% | 35 | $0.00 | |
| 3351F | 0% | 12 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 423 | $0.00 |
| 90461 | 0% | 121 | $0.00 | |
| 3062F | 0% | 206 | $0.00 | |
| 3046F | 0% | 17 | $0.00 | |
| 90633 | 0% | 19 | $0.00 | |
| 90710 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTEAGUE, BARTLEY (EXECUTIVE DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| WT University Medical Associates INC | Jackson, TN | $7.49M |
| WT Medical Associates | Dyersburg, TN | $4.96M |
| West Tennessee Healthcare Hospitalists INC | Jackson, TN | $4.30M |
| WT Medical Associates | Paris, TN | $2.48M |
| Jackson Madison County General Hospital | Jackson, TN | $1.51M |
| Martin Health | Martin, TN | $762K |
| Therapy & Learning Center INC | Jackson, TN | $83K |
| West Tennessee Healthcare Henry County | Paris, TN | $2K |
| WT Regional Medical Associates | Caruthersville, MO | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.